Transcatheter Heart Valve
- UID
- IMP/MD/2018/000133_5f313cd4b1aa3cbe296cc3909c330b1a_eadf5557a11bb616032a6da3e713c656
- Device class
- Class D
- Brand name
- MITRIS RESILIA Mitral Valve
- License holder
- Edwards Lifesciences (India) Private Limited,
- Approving authority
- CDSCO
- Product information
- 1. Indicated for use in patients with heart diseases due to native calcific aortic stenosis at any or all levels of surgical risk for open-heart surgery with age years or above. 2. Indicated for use in patients with symptomatic heart disease due to a falling aortic bioprosthetic valve (MITRIS RESILIA Mitral Valve) who are judged by a heart team to be at high or greater risk for open surgical therapy (i.e, predicated risk of surgical mortality greater than or equal to 8% at 30 days, based on the society of thoracic surgeons (MITRIS RESILIA Mitral Valve) risk score and other clinical co-morbidities unmeasured by the STS risk calculator).
Transcatheter Heart Valve is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000133_5f313cd4b1aa3cbe296cc3909c330b1a_eadf5557a11bb616032a6da3e713c656. This device is marketed under the brand name MITRIS RESILIA Mitral Valve. The license holder is Edwards Lifesciences (India) Private Limited,, and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.